Provider Burnout During COVID-19

Sponsor
University of Pittsburgh (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04370938
Collaborator
(none)
0
1
2
6
0

Study Details

Study Description

Brief Summary

Since the novel coronavirus, SARS-CoV-2, was first reported in the Hubei province of China in December 2019, the US has become an epicenter for the pandemic, accounting for more than 220,000 cases and 4,800 deaths (CDC). The rapid spread of the associated disease, COVID-19, has overwhelmed healthcare systems in spite of unprecedented measures to reduce contagion. The resulting uncertainty with regard to the duration and magnitude of the pandemic and limited availability of resources and treatment have been detrimental to the mental health of frontline healthcare providers (NIH). Preserving the psychological wellbeing of these individuals is paramount to mitigating the effect of COVID-19 and delivering optimal patient care.

Of particularly grave concern is how professional and personal distress caused by the COVID-19 pandemic will affect provider burnout (Lai et al. JAMA Network Open 2020). Professional burnout, characterized by emotional exhaustion, career de-prioritization, and loss of self-efficacy, represents a significant threat to the US healthcare system (Shanafelt et al. Ann Surg 2010; Han et al. Annals of Internal Medicine 2019). While burnout has been described as a reaction to chronic work-related stress (Melamed et al. Psychol. Bull. 2006), individual factors such as anxiety increase susceptibility to burnout (Sun et al. J Occup Health 2012). Although data suggests that occupational stress might amplify risk of anxiety (DiGiacomo and Adamson J Allied Health 2001), we have yet to understand how intensified anxiety among frontline providers during global health crises contributes to burnout. Similarly, it is unknown whether factors such as perceived organizational support (POS), a key driver of job satisfaction and performance (Muse and Stamper, J Managerial Issues 2007), modify anxiety and burnout under these circumstances. We hypothesize that diminished POS in response to the COVID-19 pandemic is associated with burnout and that this relationship is mediated by an increase in providers' anxiety. Delineating this relationship is a critical first step in developing interventions that ease the mental health burden of this pandemic and future crises for healthcare providers.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Coping strategies video
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A longitudinal survey-based research study investigating the domains of perceived organizational support, anxiety, and burnout will take place. Healthcare providers with patient-care contact will be asked to fill out these surveys once every 30 days over a period of 6 months. After the first survey is complete, 20% of participants will be randomized to watch a 1-hour long video discussing coping strategies for stress related to the COVID-19 pandemic.A longitudinal survey-based research study investigating the domains of perceived organizational support, anxiety, and burnout will take place. Healthcare providers with patient-care contact will be asked to fill out these surveys once every 30 days over a period of 6 months. After the first survey is complete, 20% of participants will be randomized to watch a 1-hour long video discussing coping strategies for stress related to the COVID-19 pandemic.
Masking:
Single (Outcomes Assessor)
Masking Description:
Individuals responsible for analyzing survey data (including that which was administered after the intervention), will be masked with regard to whether the participant received the intervention.
Primary Purpose:
Other
Official Title:
Exploring Provider Burnout During the COVID-19 Pandemic
Actual Study Start Date :
Apr 29, 2020
Anticipated Primary Completion Date :
Oct 29, 2020
Anticipated Study Completion Date :
Oct 29, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Coping strategies video

Individuals will be asked to watch a 1 hour long video that discusses strategies helpful in coping with stress during the COVID-19 pandemic.

Behavioral: Coping strategies video
No additional description

No Intervention: Control

No additional requests will be made of individuals in the control arm.

Outcome Measures

Primary Outcome Measures

  1. Feasibility of undertaking task [6 months]

    As healthcare providers have limited time, it is unclear if this request to watch a 1 hour video on coping strategies will be a feasible intervention. We will assess how many individuals endorse actually watching this video.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All UPMC healthcare providers with patient-care responsibilities (respiratory therapists, physical therapists, nursing staff, residents, attendings, midlevel providers, and clinical faculty) will be contacted via email and asked if they would be willing to participate in this study (participant recruitment email).
Exclusion Criteria:
  • All individuals <18 yo and those providers without direct patient-care responsibilities will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Pittsburgh Pennsylvania United States 15218

Sponsors and Collaborators

  • University of Pittsburgh

Investigators

  • Principal Investigator: Sara P Myers, MD, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sara Myers, General Surgery Residents, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04370938
Other Study ID Numbers:
  • STUDY20040051
First Posted:
May 1, 2020
Last Update Posted:
Dec 29, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2020